Convergence between Wnt-β-catenin and EGFR signaling in cancer
Open accessThe DOI matches its Crossref record; 77 of the 78 references it cites were found in a registry or an index.
Abstract
Wnt and EGFR signaling play key roles in embryonic development and cell proliferation. It is well documented that dysregulation of these two pathways often leads to tumorigenesis with poor prognosis. However, the possible crosstalk between the two pathways in cancer development is largely unknown. Although some reports show that EGFR might antagonize Wnt signaling during development in Drosophila, an increasing body of evidence indicates that Wnt and EGFR signaling crosstalk and transactivate one another in development and cancer. This review summarizes recent studies on the crosstalk between Wnt and EGFR signaling in cancers and points out several possible convergence points. Wnt ligands can activate EGFR signaling through their 7-transmembrane domain receptor Frizzled while EGFR can activate β-catenin via receptor tyrosine kinase-PI3K/Akt pathway; EGFR has been shown to form a complex with β-catenin and increase the invasion and metastasis of cancer cells. NKD2, a Wnt antagonist by interacting with Dishevelled, also escorts TGFα-containing exocytic vesicles to the basolateral membrane of polarized epithelial cells. Down-regulation of NKD2 causes Wnt activation and TGFα misdelivery, suggesting its functions in cell homeostasis and prevention of tumorigenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For example, EGFR can form a complex with β-catenin to activate the Wnt pathway, and the Wnt ligand can confer anti-EGFR resistance through its Frizzled activation of EGFR signaling [192,193].”
From Drug Resistance in Colorectal Cancer: From Mechanism to Clinic (2022) · cites this paper as [192]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Regulation of β-Catenin Structure and Activity by Tyrosine Phosphorylation
Piedra, J., Martı́nez, D., Castaño, J., Miravet, S., Duñach, M., & de Herreros, A. G. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100194200 · Cited by 262 · cited 1×
“cer cell lines MDA-MB-468 can induce a strong tyrosine phosphorylation of b-catenin [63], that blocks the interaction between b-catenin and E-cadherin and increases the invasiveness and metastatic potential of cancer cells [64,65].”
BackgroundRetractedA genetic model for colorectal tumorigenesis
Fearon, E. R., & Vogelstein, B. (1990) · Cell · doi:10.1016/0092-8674(90)90186-i · Cited by 12,132 · cited 1×
“lying tumor formation and progression [1].”
EGFR Mutation and Resistance of Non–Small-Cell Lung Cancer to Gefitinib
Kobayashi, S., Boggon, T. J., Dayaram, T., Jänne, P. A., Kocher, O., Meyerson, M., Johnson, B. E., Eck, M. J., Tenen, D. G., & Halmos, B. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa044238 · Cited by 3,964
Epidermal growth factor receptor mutations in lung cancer
Sharma, S. V., Bell, D. W., Settleman, J., & Haber, D. A. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2088 · Cited by 3,170 · cited 1×
“For example, among non-small cell lung cancer (NSCLC) patients, 60% have been reported with EGFR overexpression and a poor prognosis (the median survival time is around 4-5 months) [29].”
BackgroundThe T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP
Yun, C.-H., Mengwasser, K. E., Toms, A. V., Woo, M. S., Greulich, H., Wong, K.-K., Meyerson, M., & Eck, M. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709662105 · Cited by 2,118 · cited 2×
“Yun CH, Mengwasser KE, Toms AV, Woo MS, Greulich H, Wong KK, Meyerson M, Eck MJ: The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP.”
BackgroundAPC mutations occur early during colorectal tumorigenesis
Powell, S. M., Zilz, N., Beazer-Barclay, Y., Bryan, T. M., Hamilton, S. R., Thibodeau, S. N., Vogelstein, B., & Kinzler, K. W. (1992) · Nature · doi:10.1038/359235a0 · Cited by 1,924 · cited 1×
“80% of colon cancers have APC mutations [2] and 50-70% of breast, colon and lung cancers have EGFR and ErB3 mutations [28].”
BackgroundPrenzel, N., Zwick, E., Daub, H., Leserer, M., Abraham, R., Wallasch, C., & Ullrich, A. (1999) · Nature · doi:10.1038/47260 · Cited by 1,504
erb B-2 Is a Potent Oncogene When Overexpressed in NIH/3T3 Cells
Di Fiore, P. P., Pierce, J. H., Kraus, M. H., Segatto, O., King, C. R., & Aaronson, S. A. (1987) · Science · doi:10.1126/science.2885917 · Cited by 1,010 · cited 1×
“tion of NIH-3T3 cells [24,25].”
Wnt5a signaling directly affects cell motility and invasion of metastatic melanoma
Weeraratna, A. T., Jiang, Y., Hostetter, G., Rosenblatt, K., Duray, P., Bittner, M., & Trent, J. M. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00045-4 · Cited by 959 · cited 1×
“In vitro studies also confirm that Wnt5A activity increases melanoma invasiveness and that the activity is independent of b-catenin [19].”
BackgroundProstaglandin E 2 Promotes Colon Cancer Cell Growth Through a G s -Axin-ß-Catenin Signaling Axis
Castellone, M. D., Teramoto, H., Williams, B. O., Druey, K. M., & Gutkind, J. S. (2005) · Science · doi:10.1126/science.1116221 · Cited by 883 · cited 1×
“Studies indicate that prostaglandin E2 (PGE2), a product of cyclooxygenase-2 (Cox-2) activity, promotes tumor growth by activating EGFR [43] or b-catenin [ 44 ].”
BackgroundThe many ways of Wnt in cancer
Polakis, P. (2007) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2006.12.007 · Cited by 866 · cited 1×
“Canonical Wnt signaling is closely related with many cancers [10].”
BackgroundPai, R., Soreghan, B., Szabo, I. L., Pavelka, M., Baatar, D., & Tarnawski, A. S. (2002) · Nature Medicine · doi:10.1038/nm0302-289 · Cited by 836 · cited 1×
“Studies indicate that prostaglandin E2 (PGE2), a product of cyclooxygenase-2 (Cox-2) activity, promotes tumor growth by activating EGFR [43] or b-catenin [44].”
BackgroundHarris, R. (2003) · Experimental Cell Research · doi:10.1016/s0014-4827(02)00105-2 · Cited by 776 · cited 1×
“tively bind to each receptor [22].”
Dishevelled: The hub of Wnt signaling
Gao, C., & Chen, Y.-G. (2010) · Cellular Signalling · doi:10.1016/j.cellsig.2009.11.021 · Cited by 755 · cited 1×
“Dishevelled, the hub of Wnt signaling, can mediate canonical and non-canonical Wnt signaling by binding to different proteins via its different functional domains [ 8 ].”
BackgroundLu, Z., Ghosh, S., Wang, Z., & Hunter, T. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00304-0 · Cited by 647 · cited 2×
“Chronic activation of EGFR induces transcriptional down-regulation of caveolin-1, which in turn enhances b-catenin-TCF/LEF-1 transcriptional activity in a GSK-3b-independent manner [57].”
BackgroundDi Fiore, P. P., Pierce, J. H., Fleming, T. P., Hazan, R., Ullrich, A., King, C. R., Schlessinger, J., & Aaronson, S. A. (1987) · Cell · doi:10.1016/0092-8674(87)90592-7 · Cited by 640 · cited 1×
“tion of NIH-3T3 cells [24,25].”
WNT signalling in the immune system: WNT is spreading its wings
Staal, F. J. T., Luis, T. C., & Tiemessen, M. M. (2008) · Nature Reviews Immunology · doi:10.1038/nri2360 · Cited by 582
Tao, Q., Yokota, C., Puck, H., Kofron, M., Birsoy, B., Yan, D., Asashima, M., Wylie, C. C., Lin, X., & Heasman, J. (2005) · Cell · doi:10.1016/j.cell.2005.01.013 · Cited by 510 · cited 1×
“Wnt11 has recently been shown to be the activator of both canonical and non-canonical Wnt pathways [7].”
BackgroundKurayoshi, M., Oue, N., Yamamoto, H., Kishida, M., Inoue, A., Asahara, T., Yasui, W., & Kikuchi, A. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-2359 · Cited by 451 · cited 1×
“Although there are still arguments whether it is a tumor suppressor or promoter, Wnt5A overexpression has been found to be associated with aggressive tumor biology and poor prognosis [17,18].”
BackgroundPrevalence of aberrant expression of the epidermal growth factor receptor in human cancers
Gullick, W. J. (1991) · British Medical Bulletin · doi:10.1093/oxfordjournals.bmb.a072464 · Cited by 449 · cited 1×
“overexpression, mutations or deletions [23].”
Radinsky, R., Risin, S. A., Fan, D., Dong, Z., Bielenberg, D. R., Bucana, C. D., & Fidler, I. J. (1995) · PubMed · Cited by 353
TACE cleavage of proamphiregulin regulates GPCR-induced proliferation and motility of cancer cells
Gschwind, A. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg231 · Cited by 342 · cited 1×
“[61,62].”
EGFR Mutation and Resistance of Non-Small-Cell Lung Cancer to Gefitinib
Hanna, N. H. (2006) · Yearbook of Oncology · doi:10.1016/s1040-1741(08)70161-1 · Cited by 342
Target-based agents against ErbB receptors and their ligands: a novel approach to cancer treatment.
Normanno, N., Bianco, C., De Luca, A., Maiello, M. R., & Salomon, D. S. (2003) · Endocrine-related cancer · doi:10.1677/erc.0.0100001 · Cited by 336
Expression in rat fibroblasts of a human transforming growth factor-α cDNA results in transformation
Rosenthal, A., Lindquist, P. B., Bringman, T. S., Goeddel, D. V., & Derynck, R. (1986) · Cell · doi:10.1016/0092-8674(86)90747-6 · Cited by 335 · cited 1×
“Overexpression of the EGFR ligand TGFa also results in transformation of Rat-1 and NRK cells [26,27].”
BackgroundEGF mutant receptor vIII as a molecular target in cancer therapy.
Kuan, C. T., Wikstrand, C. J., & Bigner, D. D. (2001) · Endocrine-related cancer · doi:10.1677/erc.0.0080083 · Cited by 323 · cited 1×
“An in-frame deletion of exon 2-7 of EGFR is frequently detected in glioblastoma, which encodes a constitutively active EGFR protein [ 31 ].”
BackgroundThe Juxtamembrane Region of the EGF Receptor Functions as an Activation Domain
Red Brewer, M., Choi, S. H., Alvarado, D., Moravcevic, K., Pozzi, A., Lemmon, M. A., & Carpenter, G. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.04.034 · Cited by 317 · cited 1×
“the juxtamembrane region of EGFR promotes cellular transformation and tumorigenesis, suggesting this region might be an activation domain [ 35 ].”
BackgroundSharma, M., Chuang, W. W., & Sun, Z. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201919200 · Cited by 308 · cited 2×
“Studies also show that EGFR activation could induce nuclear accumulation of b-catenin via PI3K/Akt pathway in prostate cells [59,60].”
BackgroundJanssen, K., Alberici, P., Fsihi, H., Gaspar, C., Breukel, C., Franken, P., Rosty, C., Abal, M., El Marjou, F., Smits, R., et al. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.08.011 · Cited by 298
Roberts, R. B., Min, L., Washington, M. K., Olsen, S. J., Settle, S. H., Coffey, R. J., & Threadgill, D. W. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.032678499 · Cited by 275 · cited 1×
“the genesis of adenomas and maintenance of carcinomas during intestinal tumorigenesis [3].”
BackgroundJi, H., Wang, J., Nika, H., Hawke, D., Keezer, S., Ge, Q., Fang, B., Fang, X., Fang, D., Litchfield, D. W., et al. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.09.034 · Cited by 270 · cited 1×
“EGFR mediated PI3K/Akt activation promotes b-catenin transactivation and tumor cell invasion, suggesting that EGFR activation transactivate b-catenin activity via receptor tyrosine kinase pathways in tumor cells [57-60].”
BackgroundHazan, R. B., & Norton, L. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.15.9078 · Cited by 253 · cited 1×
“cer cell lines MDA-MB-468 can induce a strong tyrosine phosphorylation of b-catenin [63], that blocks the interaction between b-catenin and E-cadherin and increases the invasiveness and metastatic potential of cancer cells [64,65].”
BackgroundThe links between axin and carcinogenesis
Salahshor, S., & Woodgett, J. R. (2005) · Journal of Clinical Pathology · doi:10.1136/jcp.2003.009506 · Cited by 249 · cited 1×
“mutated in a variety of human cancers [12].”
Backgroundnaked cuticle encodes an inducible antagonist of Wnt signalling
Zeng, W., Wharton, K. A., Mack, J. A., Wang, K., Gadbaw, M., Suyama, K., Klein, P. S., & Scott, M. P. (2000) · Nature · doi:10.1038/35001615 · Cited by 241 · cited 1×
“NKD1 and NKD2 are two mammalian orthologs of Drosophila Naked cuticle and have been shown to negatively regulate canonical Wnt signaling through an interaction with Dishevelled (Dvl) [66-68].”
BackgroundInvolvement of PP2A in viral and cellular transformation
Arroyo, J. D., & Hahn, W. C. (2005) · Oncogene · doi:10.1038/sj.onc.1209038 · Cited by 238 · cited 1×
“[15].”
Schlange, T., Matsuda, Y., Lienhard, S., Huber, A., & Hynes, N. E. (2007) · Breast Cancer Research · doi:10.1186/bcr1769 · Cited by 229 · cited 2×
“Further studies showed that in breast cancers, Wnt1 transactivates EGFR, implying that constitutive Wnt signaling might impact not only the canonical pathway but also EGFR activity by augmenting ligand availability [51].”
BackgroundEpidermal Growth Factor Receptor: A Novel Target of the Wnt/β-Catenin Pathway in Liver
Tan, X., Apte, U., Micsenyi, A., Kotsagrelos, E., Luo, J.-H., Ranganathan, S., Monga, D. K., Bell, A., Michalopoulos, G. K., & Monga, S. P. S. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.04.013 · Cited by 219 · cited 2×
“b-catenin in the liver [56].”
BackgroundCanonical Wnt signaling is antagonized by noncanonical Wnt5a in hepatocellular carcinoma cells
Yuzugullu, H., Benhaj, K., Ozturk, N., Senturk, S., Celik, E., Toylu, A., Tasdemir, N., Yilmaz, M., Erdal, E., Akcali, K. C., et al. (2009) · Molecular Cancer · doi:10.1186/1476-4598-8-90 · Cited by 215 · cited 1×
“to tumor progression [21].”
Faivre, E. J., & Lange, C. A. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01539-06 · Cited by 212 · cited 2×
“In breast cancers, upregulation of Wnt-1 induces EGFR and Erk 1/2 MAPK activation [53].”
BackgroundDejmek, J., Dejmek, A., Säfholm, A., Sjölander, A., & Andersson, T. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1710 · Cited by 186 · cited 1×
“In colorectal cancers, studies show that non-canonical Wnt signaling antagonizes b-catenin dependent transcription [20], suggesting an anti-oncogenic effect of non-canonical Wnt signaling.”
BackgroundDuval, A., Gayet, J., Zhou, X., Iacopetta, B. M., Thomas, G. D., & Hamelin, R. (1999) · PubMed · Cited by 182
Agarwal, A., Das, K., Lerner, N., Sathe, S., Cicek, M., Casey, G., & Sizemore, N. (2005) · Oncogene · doi:10.1038/sj.onc.1208296 · Cited by 181
Loss of SFRP1 is associated with breast cancer progression and poor prognosis in early stage tumors
Klopocki, E., Kristiansen, G., Wild, P., Klaman, I., Castanos-Velez, E., Singer, G., Stöhr, R., Simon, R., Sauter, G., Leibiger, H., et al. (2004) · International Journal of Oncology · doi:10.3892/ijo.25.3.641 · Cited by 169 · cited 1×
“poor prognosis [49,50].”
Rosner, A., Miyoshi, K., Landesman-Bollag, E., Xu, X., Seldin, D. C., Moser, A. R., MacLeod, C. L., Shyamala, G., Gillgrass, A. E., & Cardiff, R. D. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64269-1 · Cited by 168 · cited 1×
“transgenic mice display distinct pathologies [52], sug-”
Cell autonomous regulation of multiple Dishevelled-dependent pathways by mammalian Nkd
Yan, D., Wallingford, J. B., Sun, T.-Q., Nelson, A. M., Sakanaka, C., Reinhard, C., Harland, R. M., Fantl, W. J., & Williams, L. T. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.071041898 · Cited by 167 · cited 1×
“NKD1 and NKD2 are two mammalian orthologs of Drosophila Naked cuticle and have been shown to negatively regulate canonical Wnt signaling through an interaction with Dishevelled (Dvl) [66-68].”
BackgroundHuang, C.-L., Liu, D., Nakano, J., Ishikawa, S., Kontani, K., Yokomise, H., & Ueno, M. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.2871 · Cited by 165 · cited 1×
“Although there are still arguments whether it is a tumor suppressor or promoter, Wnt5A overexpression has been found to be associated with aggressive tumor biology and poor prognosis [ 17 ,18].”
Backgroundnaked cuticle targets dishevelled to antagonize Wnt signal transduction
Rousset, R., Mack, J. A., Wharton, K. A., Axelrod, J. D., Cadigan, K. M., Fish, M. P., Nusse, R., & Scott, M. P. (2001) · Genes & Development · doi:10.1101/gad.869201 · Cited by 158 · cited 1×
“NKD1 and NKD2 are two mammalian orthologs of Drosophila Naked cuticle and have been shown to negatively regulate canonical Wnt signaling through an interaction with Dishevelled (Dvl) [66-68].”
BackgroundCivenni, G., Holbro, T., & Hynes, N. E. (2003) · EMBO reports · doi:10.1038/sj.embor.embor735 · Cited by 132 · cited 2×
“When Wnt1 and Wnt5a bind to Frizzled, it transactivates EGFR signaling by matrix metalloproteinase-mediated release of soluble EGFR ligands [ 55 ].”
BackgroundEGFRMutation and Response of Lung Cancer to Gefitinib
Toyooka, S., Kiura, K., & Mitsudomi, T. (2005) · New England Journal of Medicine · doi:10.1056/nejm200505193522019 · Cited by 127 · cited 1×
“Tumors with both T790M and L858R are more aggressive [ 34 ].”
BackgroundShibata, T., Ochiai, A., Kanai, Y., Akimoto, S., Gotoh, M., Yasui, N., Machinami, R., & Hirohashi, S. (1996) · PubMed · Cited by 126
Ugolini, F., Adélaı̈de, J., Charafe‐Jauffret, E., Nguyen, C., Jacquemier, J. D., Jordan, B., Birnbaum, D., & Pébusque, M. (1999) · Oncogene · doi:10.1038/sj.onc.1202739 · Cited by 124 · cited 1×
“poor prognosis [49,50].”
Moran, A. E., Hunt, D. H., Javid, S. H., Redston, M., Carothers, A. M., & Bertagnolli, M. M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m404276200 · Cited by 112 · cited 2×
“In Min/+ tumors, in which Wnt activity is high, PGE2 is up-regulated and transactivates EGFR [45].”
BackgroundAntagonism between EGFR and Wingless signalling in the larval cuticle of Drosophila
Szüts, D., Freeman, M., & Bienz, M. (1997) · Development · doi:10.1242/dev.124.16.3209 · Cited by 112
Watanabe, S., Lazar, E., & Sporn, M. B. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.5.1258 · Cited by 108 · cited 1×
“Overexpression of the EGFR ligand TGFa also results in transformation of Rat-1 and NRK cells [26,27].”
BackgroundJc, L., Wang, S.-T., Chow, N.-H., & Yang, H.-B. (2002) · European Journal of Cancer · doi:10.1016/s0959-8049(02)00004-7 · Cited by 106 · cited 1×
“Additional study shows that co-expression of different ErbB receptors is usually associated with a worse prognosis compared to single receptor overexpression in cancers [30].”
BackgroundGross, M. E., Zorbas, M. A., Danels, Y. J., García, R., Gallick, G. E., Olivé, M., Brattain, M. G., Boman, B. M., & Yeoman, L. C. (1991) · PubMed · Cited by 94
Suzuki, M., Shigematsu, H., Nakajima, T., Kubo, R., Motohashi, S., Sekine, Y., Shibuya, K., Iizasa, T., Hiroshima, K., Nakatani, Y., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0591 · Cited by 90 · cited 2×
“In NSCLC, there is a positive correlation between activated EGFR mutation and nuclear accumulation of b-catenin [47].”
BackgroundThe complex pathways of Wnt 5a in cancer progression
Pukrop, T., & Binder, C. R. (2007) · Journal of Molecular Medicine · doi:10.1007/s00109-007-0266-2 · Cited by 89 · cited 1×
“There is strong evidence that Wnt5A, the non-canonical Wnt ligand, is involved in cancer progression [16].”
BackgroundSchroeder, J. A., Adriance, M. C., McConnell, E. J., Thompson, M. C., Pockaj, B., & Gendler, S. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201975200 · Cited by 76 · cited 2×
“Subsequent work indicated a direct interaction between b-catenin and EGFR/ErbB2 heterodimers in mammary gland tumors [46].”
BackgroundLi, C., Franklin, J. L., Graves-Deal, R., Jerome, W. G., Cao, Z., & Coffey, R. J. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401294101 · Cited by 73 · cited 1×
“toylation-dependent manner [71].”
Self-citationZebrafish Naked1 and Naked2 antagonize both canonical and non-canonical Wnt signaling
Raay, T. J. V., Coffey, R. J., & Solnica‐Krezel, L. (2007) · Developmental Biology · doi:10.1016/j.ydbio.2007.04.018 · Cited by 70 · cited 1×
“In zebrafish, NKD1 and NKD2 antagonize both canonical and noncanonical Wnt signaling [69].”
BackgroundNoncanonical Wnt Signaling in Tumor Progression and Metastasis
Jessen, J. R. (2009) · Zebrafish · doi:10.1089/zeb.2008.0571 · Cited by 64 · cited 1×
“that non-canonical Wnt signaling also promotes the invasiveness and metastasis of different cancers [9].”
BackgroundKim, S., & Choi, K. (2007) · Cellular Signalling · doi:10.1016/j.cellsig.2007.02.003 · Cited by 63 · cited 1×
“[41].”
Hu, T., Li, C., Cao, Z., Van Raay, T. J., Smith, J. G., Willert, K., Solnica-Krezel, L., & Coffey, R. J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.075945 · Cited by 60 · cited 2×
“show that NKD2 forms a mutual degradation complex with Dvl-1 [76], and that TGFa stabilizes NKD2 by suppressing the binding between NKD2 and its ubiquitin ligase AO7 [75].”
BackgroundSelf-citationFreeman, M., & Bienz, M. (2001) · EMBO reports · doi:10.1093/embo-reports/kve019 · Cited by 54 · cited 1×
“eye [37].”
Weber, U., Pataki, C. A., Mihály, J., & Mlodzik, M. (2008) · Developmental Biology · doi:10.1016/j.ydbio.2008.01.016 · Cited by 52 · cited 1×
“elegans male hook development [39,40].”
Guo, J., Çağatay, T., Zhou, G., Chan, C., Blythe, S. A., Suyama, K. L., Li, Z., Pan, K., Qian, C., Hamelin, R., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007982 · Cited by 50 · cited 1×
“been shown mutated in colorectal cancers [14].”
Cao, Z., Li, C., Higginbotham, J. N., Franklin, J. L., Tabb, D. L., Graves-Deal, R., Hill, S., Cheek, K., Jerome, W. G., Lapierre, L. A., et al. (2008) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m700155-mcp200 · Cited by 46 · cited 1×
“recognition and targeting protein to ensure proper delivery and fusion of TGFa-containing exocytic vesicles [72-74].”
BackgroundSelf-citationLi, C., Hao, M., Cao, Z., Ding, W., Graves-Deal, R., Hu, J., Piston, D. W., & Coffey, R. J. (2007) · Molecular Biology of the Cell · doi:10.1091/mbc.e07-02-0172 · Cited by 43 · cited 1×
“recognition and targeting protein to ensure proper delivery and fusion of TGFa-containing exocytic vesicles [72-74].”
BackgroundSelf-citationMolecular cloning, gene structure, and expression analyses of NKD1 and NKD2
Katoh, M. (2001) · International Journal of Oncology · doi:10.3892/ijo.19.5.963 · Cited by 38 · cited 1×
“date tumor suppressors [70].”
Cooperative induction of mammary tumorigenesis by TGFα and Wnts
Schroeder, J. A., Troyer, K. L., & Lee, D. C. (2000) · Oncogene · doi:10.1038/sj.onc.1203652 · Cited by 35 · cited 1×
“These results indicate a collaboration between Wnt and EGFR signaling pathways in mammary gland tumorigenesis and suggest a convergence between their ligands (Wnt3 and TGFa ) [42].”
BackgroundWnt signalling via the epidermal growth factor receptor: a role in breast cancer?
Musgrove, E. A. (2003) · Breast Cancer Research · doi:10.1186/bcr737 · Cited by 33 · cited 1×
“In breast cancers, Wnt overexpression activates signaling via EGFR [53,54].”
BackgroundKarbova, E., Davidson, B., Metodiev, K., Trope, C. G., & Nesland, J. M. (2002) · International Journal of Surgical Pathology · doi:10.1177/106689690201000302 · Cited by 30 · cited 1×
“In ovarian tumors, APC was found to be absent in all tumors with nuclear b-catenin staining [11].”
BackgroundNagaraj, R., & Banerjee, U. K. (2009) · The EMBO Journal · doi:10.1038/emboj.2008.286 · Cited by 28 · cited 1×
“phila [38].”
Ding, W., Li, C., Hu, T., Graves‐Deal, R., Fotia, A. B., Weissman, A. M., & Coffey, R. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0806298105 · Cited by 20
Self-citationStructural studies of human Naked2: A biologically active intrinsically unstructured protein
Hu, T., Krezel, A. M., Li, C., & Coffey, R. J. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.09.121 · Cited by 18 · cited 1×
“recognition and targeting protein to ensure proper delivery and fusion of TGFa-containing exocytic vesicles [72-74].”
BackgroundSelf-citationWnt and EGF pathways act together to induce C. elegans male hook development
Yu, H. M., Seah, A., Herman, M. A., Ferguson, E. L., Horvitz, H. R., & Sternberg, P. W. (2008) · Developmental Biology · doi:10.1016/j.ydbio.2008.12.023 · Cited by 17 · cited 1×
“elegans male hook development [39,40].”
Cited by
Targeting the Wnt/β-catenin signaling pathway in cancer
Zhang, Y., & Wang, X. (2020) · Journal of Hematology & Oncology · doi:10.1186/s13045-020-00990-3 · Cited by 1,431
Godoy, P., Hewitt, N. J., Albrecht, U., Andersen, M. E., Ansari, N., Bhattacharya, S., Bode, J. G., Bolleyn, J., Borner, C., Böttger, J., et al. (2013) · Archives of Toxicology · doi:10.1007/s00204-013-1078-5 · Cited by 1,280
“Hepatocytes from PXR knockout mice express higher levels of inflammatory cytokines such as IL-1b and TNF-a compared to wild-type mice (Hu and Li 2010; Zhou et al. 2006).”
InfluentialPolakis, P. (2012) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a008052 · Cited by 847
“These include direct binding of b-catenin to EGFR, modulation of the cadherin-b-catenin interface by EGFR, activation ofb-catenin-dependent signaling by EGFR through PI3K signaling as well as the EGFR gene itself as a Wnt target (review by Hu and Li 2011).”
BackgroundTargeting cytokine and chemokine signaling pathways for cancer therapy
Yi, M., Li, T., Niu, M., Zhang, H., Wu, Y., Wu, K., & Dai, Z. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01868-3 · Cited by 455
Lu, Y., Zhao, X., Liu, Q., Li, C., Graves-Deal, R., Cao, Z., Singh, B., Franklin, J. L., Wang, J., Hu, H., et al. (2017) · Nature Medicine · doi:10.1038/nm.4424 · Cited by 425
Self-citation
Metadata
- Authors
- Hu, T., & Li, C.
- Affiliations
- Xiamen University (CN)
- Vanderbilt University (US)
- Corresponding author
- Hu, Tianhui
- Li, Cunxi
- ORCID
- Venue
- Molecular Cancer
- Published
- 2010
- Volume
- 9
- Issue
- 1
- Pages
- 236
- ISSN
- 1476-4598 (ISSN-L)
- PMC
- PMC2944186
- OpenAlex
- W2130473918
- Semantic Scholar
- 37699e551487b2e80611f69ed570cf299df50f6e
- Cited by
- 291
- References
- 78
- Citations by year
- 2026: 16 · 2025: 14 · 2024: 21 · 2023: 18 · 2022: 11 · 2021: 18 · 2020: 19 · 2019: 14 · 2018: 21 · 2017: 19 · 2016: 19 · 2015: 26 · 2014: 20 · 2013: 21 · 2012: 19
- FWCI
- 1.55
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- Locations
- Molecular Cancer (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- National Natural Science Foundation of China (30971524)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Wnt/β-catenin signaling in development and cancer
- Health Sciences › Medicine › Oncology › Colorectal Cancer Treatments and Studies
- Health Sciences › Medicine › Oncology › HER2/EGFR in Cancer Research
- Keywords
- Wnt signaling, EGFR signaling, pathway crosstalk, β-catenin, Frizzled receptors, PI3K/Akt signaling, NKD2, epithelial polarization, tumor invasion and metastasis, carcinogenesis, Dishevelled
- MeSH terms
- Animals, Humans, Models, Biological, Neoplasms, Signal Transduction, Wnt Proteins, beta Catenin, ErbB Receptors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.